ARTICLE
19 March 2025

Pharma TM Articles

R
Rouse

Contributor

Rouse is an IP services business focused on emerging markets. We operate as a closely integrated network to provide the full range of intellectual property services, from patent and trade mark protection and management to commercialisation, global enforcement and anti-counterfeiting.
A range of articles from Rouse since 2018 covering IP legal developments impacting the pharmaceutical industry...
United Kingdom Food, Drugs, Healthcare, Life Sciences
Rouse are most popular:
  • within Privacy topic(s)
  • with readers working within the Retail & Leisure industries

A range of articles from Rouse since 2018 covering IP legal developments impacting the pharmaceutical industry:

Rouse - Cambodia: Anti counterfeiting industry activity in Cambodia

Rouse - Indonesia compulsory licensing scare

Rouse - Pharma boss arrested for allegedly selling 'deadly' counterfeit drugs

Rouse - The trade in fakes from and through Southeast Asia

Rouse - Online e-commerce platform medicine sales halted in Philippines

Rouse - New product labelling rules in Indonesia

Rouse - Pharma and consumer health product counterfeiting across South East Asia

Rouse - Thailand invalidates all cannabis patents

Rouse - Vaccines and IP in Southeast Asia

Rouse - Safeguarding the intellectual property of European SMEs

Rouse - Phase 1 of China & USA Trade Agreement: Pharmaceutical related IP issues

Rouse - Fake medicines in Southeast Asia

Rouse - Data Exclusivity in Drug Manufacturing in ASEAN

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More